Cephagenix Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $10.5M

  • Investors
  • 4

Cephagenix General Information

Description

Developer of migraine treatments intended to address the underlying mechanisms of the condition. The company focuses on identifying and developing selective inhibitors of the adenosine triphosphate-sensitive potassium channel subtype expressed in intracranial arteries, with compounds demonstrating efficacy in preclinical migraine models, enabling individuals suffering from migraine to develop treatments through targeted and mechanism-based therapies.

Contact Information

Website
www.cephagenix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 rue Thénard
  • Biolabs Hôtel Dieu PARIS
  • 75005 Paris
  • France
Primary Industry
Drug Discovery
Vertical(s)
HealthTech
Corporate Office
  • 4 rue Thénard
  • Biolabs Hôtel Dieu PARIS
  • 75005 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cephagenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 10-Sep-2025 $10.5M Completed Startup
1. Joint Venture 01-Jan-2020 Completed Startup
To view Cephagenix’s complete valuation and funding history, request access »

Cephagenix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed Shares
To view Cephagenix’s complete cap table history, request access »

Cephagenix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
AbbVie Ventures Corporate Venture Capital Minority
AdBio partners Venture Capital Minority
JOHealth Corporation Majority
Saniona Corporation Majority
To view Cephagenix’s complete investors history, request access »

Ready to get started?

Request a free trial

Cephagenix FAQs

  • When was Cephagenix founded?

    Cephagenix was founded in 2020.

  • Where is Cephagenix headquartered?

    Cephagenix is headquartered in Paris, France.

  • What industry is Cephagenix in?

    Cephagenix’s primary industry is Drug Discovery.

  • Is Cephagenix a private or public company?

    Cephagenix is a Private company.

  • What is Cephagenix’s current revenue?

    The current revenue for Cephagenix is .

  • How much funding has Cephagenix raised over time?

    Cephagenix has raised $10.5M.

  • Who are Cephagenix’s investors?

    AbbVie Ventures, AdBio partners, JOHealth, and Saniona have invested in Cephagenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process